Literature DB >> 29182604

Prostate cancer: H2A.Zac activates neo-enhancers.

Clemens Thoma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29182604     DOI: 10.1038/nrurol.2017.202

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.

Authors:  Fátima Valdés-Mora; Cathryn M Gould; Yolanda Colino-Sanguino; Wenjia Qu; Jenny Z Song; Kylie M Taylor; Fabian A Buske; Aaron L Statham; Shalima S Nair; Nicola J Armstrong; James G Kench; Kenneth M L Lee; Lisa G Horvath; Minru Qiu; Alexei Ilinykh; Nicole S Yeo-Teh; David Gallego-Ortega; Clare Stirzaker; Susan J Clark
Journal:  Nat Commun       Date:  2017-11-07       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.